-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Inovio Pharmaceuticals, Maintains $5 Price Target

Benzinga·11/12/2026 11:52:02
Diffusion vocale
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Buy and maintains $5 price target.